$39.99
-1.86-4.44%
At close: Nov 11, 4:00 PM EST
$40.01
-1.84-4.4%
Pre-Market: 8:05 AM EST
Roivant Sciences Ltd
ROIVNASDAQ
Roivant Sciences (ROIV) earnings history, EPS estimates, revenue forecasts and company guidance.
Earnings Per Share (Non-GAAP)
| Fiscal Quarter | Date Reported | Actual EPS | Estimated EPS | Surprise % |
|---|---|---|---|---|
| Q2 | Nov 9, 2026 | $-0.27 | $-0.46 | 41.3 % |
| Q1 | Aug 6, 2026 | $-0.34 | $-0.37 | 8.11 % |
| Q4 | May 20, 2026 | $-0.27 | $-0.36 | 23.9 % |
| Q3 | Feb 6, 2026 | $-0.24 | $-0.34 | 29.4 % |
Quarterly Revenue (Billions)
| Fiscal Quarter | Date Reported | Actual Revenue | Estimated Revenue | Surprise % |
|---|---|---|---|---|
| Q2 | Nov 9, 2026 | $35.12M | $3.81M | 822.5 % |
| Q1 | Aug 6, 2026 | $1.44M | $2.35M | -38.5 % |
| Q4 | May 20, 2026 | $2.52M | $3.68M | -31.6 % |
| Q3 | Feb 6, 2026 | $2.00M | $6.13M | -67.4 % |
| Metric | Q2 '27 | Q1 '27 | Q4 '26 | Q3 '26 |
|---|---|---|---|---|
| Earnings Per Share (Non-GAAP) | ||||
| Estimate | $-0.46 | $-0.37 | $-0.36 | $-0.34 |
| Actual | $-0.27 | $-0.34 | $-0.27 | $-0.24 |
| Surprise | +41.3% | +8.11% | +23.9% | +29.4% |
| Revenue | ||||
| Estimate | $3.8M | $2.3M | $3.7M | $6.1M |
| Actual | $35.1M | $1.4M | $2.5M | $2.0M |
| Surprise | +822.5% | -38.5% | -31.6% | -67.4% |
| Metric | Q3 '27E | Q4 '27E |
|---|---|---|
| Earnings Per Share (Non-GAAP) | ||
| Consensus | $-0.42 | $-0.43 |
| Revenue | ||
| Consensus | $48.2M | $65.3M |
